Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2023 Jul 25;23:697. doi: 10.1186/s12885-023-11206-5

Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma

Qingwu Du 1,#, Xiaoyue Wu 1,#, Kunning Zhang 1, Fuliang Cao 2, Gang Zhao 3, Xiaoying Wei 1, Zhoubo Guo 1, Yang Li 1, Jie Dong 4, Tian Zhang 1, Wencheng Zhang 1, Ping Wang 1,, Xi Chen 1,, Qingsong Pang 1,
PMCID: PMC10367337  PMID: 37491217

Correction: BMC Cancer 23, 681 (2023)

https://doi.org/10.1186/s12885-023-10803-8

Following publication of the original article [1], the authors identified that the versions of Fig. 2 and Fig. 4 are incorrect. The figures published in this correction article are correct and the original article [1] has been corrected.

Fig. 2.

Fig. 2

Distributions of tumor remission (A), tumor thickness (B) and lumen involvement (C) at baseline and during treatment between responders and non-responders

Fig. 4.

Fig. 4

Construction and validation of the nomogram for predicting PFS and OS. The nomogram for predicting 1-, 2-, and 3-year PFS (A) and OS (D) of patients with ESCC. Time-dependent ROC curves of the nomogram for PFS (B, C) and OS (E, F) prediction in the training and the testing cohorts. Abbreviations: ER, excellent remission; SLI, spatial luminal involvement; PFS, progression-free survival; OS, overall survival

Footnotes

Qingwu Du and Xiaoyue Wu contributed equally to this work.

Contributor Information

Ping Wang, Email: wangping@tjmuch.com.

Xi Chen, Email: chenxitj@tmu.edu.cn.

Qingsong Pang, Email: pangqingsong@tjmuch.com.

Reference

  • 1.Du Q, Wu X, Zhang K, et al. Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma. BMC Cancer. 2023;23:681. doi: 10.1186/s12885-023-10803-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES